Aim: To assess the role of human bocavirus 1 (HBoV1) as a causative agent of nonsevere community-acquired pneumonia (CAP) in children. 
Conclusion: HBoV1 was detected by PCR in one fifth of the children with non-severe CAP and acute HBoV1 infection was serologically confirmed in one quarter of these cases.
K E Y W O R D S
acute respiratory infection, children, lower respiratory tract infection, respiratory virus, viral infection 1 | INTRODUCTION Community-acquired pneumonia (CAP) remains a major cause of hospitalization and death among children under 5 years of age worldwide. 1 Due to its significance in public health and social economy development, 2 effective measures are needed to control this condition. 3 The real role of respiratory viruses in the pathogenesis of CAP remains debatable. This concerns especially human bocavirus 1 (HBoV1) which is mostly detected with other respiratory viruses and is often detected in asymptomatic subjects. 4 HBoV1 has, since its discovery in 2005, 5 been found in 10-20% of nasopharyngeal aspirate samples (NPA) of hospitalized children with lower respiratory illness. [6] [7] [8] However, HBoV1-DNA has been shown to persist for weeks or even months after an acute infection, detectable as low viral loads in the NPAs, questioning the clinical value of PCR-based diagnosis. 9 In 2008, it was shown that by measurement of HBoV1-specific IgM and IgG antibodies, it was possible to diagnose acute HBoV1 infection in children hospitalized with acute severe respiratory diseases. 9 In the current study, we used specific serology to assess the frequency of acute HBoV1 infections in children with both non-severe CAP and with HBoV1-DNA detected by PCR in the nasopharyngeal mucus. In addition, an in-house PCR test was used to detect EV and RV in NPA samples, as previously described. 15 Due to the known long persistence 17 Borderline results in all EIAs were considered indeterminate.
| MATERIALS AND METHODS

| Study design
| Preventive measures for PCR contamination
The PCR methodology is highly vulnerable to possible false positive results due to contamination of reagents and specimens with PCR amplicons. The analyses were performed in an accredited clinical virus diagnostic laboratory. In the present work, rigorous measures were taken throughout the whole study to avoid amplicon as well as sampleto-sample contamination. 
| Statistical analyses
| RESULTS
A total of 820 children were enrolled in the clinical trial. Of these, 759
(92.6%) children had NPA and acute and convalescent serum samples collected and were included in this study. The median (IQR) interval between collection of acute and convalescent samples was 19 (16) (17) (18) (19) (20) (21) (22) days. Figure 1 demonstrates the frequency of each respiratory virus found among these cases. Rhinovirus was the most frequently found virus being detected in 50% of these cases whereas neither Flu A nor PIV 2 were detected. Table 1 The widely used multiplex PCR tests have greatly increased our understanding of the role of respiratory viruses in pneumonia. In many studies in children with CAP, respiratory viruses have been detected in 50-70% of the cases. 4 However, many viruses including HBoV1 have been detected at similar or higher rates in asymptomatic controls which has questioned whether these viruses are causative agents of CAP. [21] [22] [23] Our study has certain limitations. The study was a single center study limiting wider generalization of the observations. Due to economical restrictions, HBoV1 serology was studied only from HBoV1-DNA-positive patients. It is probable that also studying HBoV1-DNA-negative CAP children would have increased our diagnostic yield. In the study on acute wheezing 13% of children 
FIGURE 2
Monthly distribution (n) of cases with acute human bocavirus 1 infection diagnosed by serology, of cases with human bocavirus 1 detected in nasopharyngeal aspirate samples, and of the recruited community-acquired pneumonia cases in each month of the study period who tested negative for HBoV1-DNA in the nasopharynx showed serologic evidence of acute HBoV1 infection. 9 Furthermore, we did not study HBoV1 copy numbers nor HBoV1 DNA in the serum.
However, it has been previously shown in a Finnish study that 38%
of the children with low-load PCR positivity have acute infection diagnosed by serology whereas 96% of the high-load positive PCR have the same serological diagnosis. 16 Therefore, serology should be enough to show reliably the actual acute infections. Moreover, it was very recently published that when compared with serology, DNA PCR had high clinical sensitivity (100%) but, because of viral persistence, low specificity (76%). 32 An additional limitation is that no virus-bacterial co-infections were analyzed. The strength of our study includes a long recruitment period lasting almost four and half years, reducing the risk of bias regarding viral seasonality, and a high number of CAP patients. In addition, the serologic studies were carried out in a well-established laboratory of HBoV1 virology. It has been recognized that serology is the most accurate method to diagnose acute HBoV1 infection, even when it was compared to detection of HBoV1 messenger RNA which implies viral replication. 32 In conclusion, our observations provide further support for the causal role of HBoV1 in the pathogenesis of childhood CAP, both as a sole agent or with other respiratory viruses.
